Do you offer durvalumab in combination with gemcitabine and cisplatin in patients with metastatic ampullary adenocarcinoma, given the fact that ABC-02 trial included patients with ampullary adenocarcinoma while TOPAZ trial excluded those patients?
Community PollStarted
For which tumor types will you plan to use durva + gem/cis?
48 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet Member
Medical Oncology · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Answered on
Unfortunately we don't have robust contemporary data for ampullary adenocarcinoma. In general I would not apply the TOPAZ-1 study findings to this population.
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Medical Oncology · Johns Hopkins University
Answered on
I do not.
Join for free or sign in to see the full answer